Caricamento...

TCR-Engineered, Customized, Antitumor T Cells for Cancer Immunotherapy: Advantages and Limitations

The clinical outcome of the traditional adoptive cancer immunotherapy approaches involving the administration of donor-derived immune effectors, expanded ex vivo, has not met expectations. This could be attributed, in part, to the lack of sufficient high-avidity antitumor T-cell precursors in most c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:ScientificWorldJournal
Autore principale: Chhabra, Arvind
Natura: Artigo
Lingua:Inglês
Pubblicazione: TheScientificWorldJOURNAL 2011
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5720046/
https://ncbi.nlm.nih.gov/pubmed/21218269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1100/tsw.2011.10
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !